Client News

CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA(R) in gene therapy

sterna biologicals GmbH & Co. KG raises further EUR 10.0 million (approx. USD 11.9 million) in Series A – 2nd closing private placement

RedHill Biopharma’s RHB-204 Granted FDA Fast Track Designation for NTM Disease

Atriva Therapeutics obtains approval from German authorities for Phase II trial in COVID-19 patients, led by Charité Clinic in Berlin

Abivax Publishes Review in Drug Discovery Today on Mechanism of Action and Transformative Potential of ABX464 as Therapy for Inflammatory Diseases

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development

Adrenomed AG: Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

4basebio AG announces changes to the Management Board

Abivax’s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government’s Clinical Trial Council